Holen Sie sich die Stockscreener-App
1.26
9.57%
0.11
Handel nachbörslich:
1.20
-0.06
-4.76%
Schlusskurs vom Vortag:
$1.15
Offen:
$1.2299
24-Stunden-Volumen:
995.67K
Relative Volume:
2.32
Marktkapitalisierung:
$77.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-60.36M
KGV:
-0.2868
EPS:
-4.394
Netto-Cashflow:
$-15.05M
1W Leistung:
+24.75%
1M Leistung:
+3.28%
6M Leistung:
-56.25%
1J Leistung:
-69.93%
1-Tages-Spanne:
$1.1604
$1.30
1-Wochen-Bereich:
$0.98
$1.30
52-Wochen-Spanne:
$0.97
$5.07
Zura Bio Ltd Stock (ZURA) Company Profile
Firmenname
Zura Bio Ltd
Sektor
Branche
Telefon
858-247-0520
Adresse
4225 EXECUTIVE SQUARE, LA JOLLA
Vergleichen Sie ZURA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZURA
Zura Bio Ltd
|
1.26 | 63.11M | 0 | -60.36M | -15.05M | -4.394 |
|
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.69B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 114.81B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.232 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
84.34 | 6.60B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 65.36B | 14.09B | 4.50B | 2.96B | 39.28 |
Zura Bio Ltd Stock (ZURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-04 | Eingeleitet | Leerink Partners | Outperform |
| 2024-09-05 | Eingeleitet | H.C. Wainwright | Neutral |
| 2024-05-03 | Eingeleitet | Piper Sandler | Overweight |
| 2023-10-10 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2023-08-25 | Eingeleitet | Oppenheimer | Outperform |
| 2023-06-22 | Eingeleitet | Guggenheim | Buy |
| 2023-06-14 | Eingeleitet | Chardan Capital Markets | Buy |
| 2023-05-24 | Eingeleitet | Raymond James | Strong Buy |
Alle ansehen
Zura Bio Ltd Aktie (ZURA) Neueste Nachrichten
Millennium Management LLC Has $1.75 Million Position in Zura Bio Limited (NASDAQ:ZURA) - Defense World
Northern Trust Corp Has $1.01 Million Stake in Zura Bio Limited (NASDAQ:ZURA) - Defense World
Zura Bio Limited (NASDAQ:ZURA) Receives $14.33 Consensus Target Price from Analysts - Defense World
Zura Bio to Present at the Jefferies Global Healthcare Conference - Yahoo Finance
Zura Bio shareholders approve board nominees and auditor - Investing.com Australia
Zura Bio shareholders approve board nominees and auditor By Investing.com - Investing.com South Africa
Q1 Earnings Forecast for Zura Bio Issued By HC Wainwright - Defense World
Zura Bio begins phase 2 trial for hidradenitis suppurativa treatment - Investing.com Australia
Zura Bio begins phase 2 trial for hidradenitis suppurativa treatment By Investing.com - Investing.com India
Zura Bio (ZURA) Initiates Phase 2 Study for Tibulizumab in HS Treatment | ZURA Stock News - GuruFocus
Cubist Systematic Strategies LLC Makes New $62,000 Investment in Zura Bio Limited (NASDAQ:ZURA) - Defense World
Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa - Quantisnow
Dimensional Fund Advisors LP Acquires New Holdings in Zura Bio Limited (NASDAQ:ZURA) - Defense World
Wells Fargo & Company MN Grows Stock Holdings in Zura Bio Limited (NASDAQ:ZURA) - Defense World
Barclays PLC Boosts Stock Position in Zura Bio Limited (NASDAQ:ZURA) - Defense World
Raymond James Financial Inc. Invests $371,000 in Zura Bio Limited (NASDAQ:ZURA) - Defense World
Oppenheimer Lowers Zura Bio (NASDAQ:ZURA) Price Target to $17.00 - Defense World
ZURA Stock Rating Maintained; Price Target Lowered by Oppenheime - GuruFocus
ZURA: Oppenheimer Revises Price Target Amid Ongoing Trials | ZUR - GuruFocus
ZURA Stock Rating Maintained; Price Target Lowered by Oppenheimer | ZURA Stock News - GuruFocus
Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates - Yahoo Finance
Ratio Analysis: Unpacking Zura Bio Ltd (ZURA)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
Zura Bio Ltd Inc. (ZURA) Price Performance: The Role of Share Buybacks and Stock Splits - investchronicle.com
Do investors need to be concerned about Zura Bio Ltd (ZURA)? - uspostnews.com
Geode Capital Management LLC Increases Stake in Zura Bio Limited (NASDAQ:ZURA) - Defense World
After losing 56% in the past year, Zura Bio Limited (NASDAQ:ZURA) institutional owners must be relieved by the recent gain - Yahoo
ZURA overperforms with a 8.76 increase in share price - uspostnews.com
Zura Bio Limited (NASDAQ:ZURA) Receives $14.67 Average Price Target from Analysts - Defense World
HC Wainwright Has Negative Estimate for Zura Bio Q1 Earnings - Defense World
HC Wainwright Lowers Zura Bio (NASDAQ:ZURA) Price Target to $3.00 - Defense World
ZURA stock touches 52-week low at $1.07 amid market challenges By Investing.com - Investing.com South Africa
H.C. Wainwright cuts Zura Bio stock target to $3, keeps neutral rating - Investing.com Australia
ZURA stock touches 52-week low at $1.07 amid market challenges - Investing.com
H.C. Wainwright cuts Zura Bio stock target to $3, keeps neutral rating By Investing.com - Investing.com South Africa
Insiders' US$1.01m Investments In Red Following Zura Bio's US$21m Dip In Market Value - simplywall.st
Cantor Fitzgerald Forecasts Weaker Earnings for Zura Bio - Defense World
Zura Bio (NASDAQ:ZURA) Price Target Lowered to $10.00 at Chardan Capital - Defense World
Zura Bio Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
Chardan cuts Zura Bio stock target to $10, keeps buy rating By Investing.com - Investing.com South Africa
Chardan cuts Zura Bio stock target to $10, keeps buy rating - Investing.com Australia
Guggenheim maintains Zura Bio stock buy rating, $15 target By Investing.com - Investing.com Australia
Guggenheim maintains Zura Bio stock buy rating, $15 target - Investing.com
Leerink maintains $12 target on Zura Bio stock post-earnings By Investing.com - Investing.com Australia
Leerink maintains $12 target on Zura Bio stock post-earnings - Investing.com
Zura Bio Ltd expected to post a loss of 16 cents a shareEarnings Preview - TradingView
Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates - Yahoo Finance
Zura Bio (ZURA) Projected to Post Quarterly Earnings on Thursday - Defense World
Zura Bio Limited (NASDAQ:ZURA) Receives $15.80 Consensus Price Target from Analysts - Defense World
Rhumbline Advisers Has $94,000 Stock Position in Zura Bio Limited (NASDAQ:ZURA) - Defense World
(Bi-)specific gravity: Bambusa, others serious about approach - BioWorld MedTech
Zura Bio to Present at the Leerink Partners Global Healthcare Conference - Yahoo Finance
Finanzdaten der Zura Bio Ltd-Aktie (ZURA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Zura Bio Ltd-Aktie (ZURA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Thiara Parvinder | Director |
Sep 11 '24 |
Sale |
2.70 |
3,800,000 |
10,260,000 |
1,001,633 |
| Sidhu Someit | Director |
Sep 04 '24 |
Sale |
3.87 |
51,728 |
200,187 |
2,085,418 |
0.00%
2.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):